AVERROES Study Closes Early Due to Clear Evidence of Efficacy
- Details
- Category: Bristol-Myers Squibb

Ranbaxy Launches Antiplatelet Agent Prasugrel in India
- Details
- Category: Daiichi Sankyo

Americans Are Not Taking Action to Protect Themselves Against Muscle Loss
- Details
- Category: Abbott

Sanofi Pasteur Partners with Vivalis for the Discovery of Human Monoclonal Antibodies
- Details
- Category: Sanofi

Merck Resubmits U.S. Application for Cladribine Tablets
- Details
- Category: Merck Group

Phase III study showed Avastin-based regimen helped women with advanced ovarian cancer
- Details
- Category: Roche

Phase 3 Study Showed MACUGEN® Improved Vision Over Standard of Care
- Details
- Category: Pfizer

More Pharma News ...
- Merck Announces Launch of Pioneering Collaborative Cancer Trials Network
- FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women with Osteoporosis
- Victoza® to be launched in Japan in June
- AstraZeneca Receives FDA Complete Response Letter for AXANUM New Drug Application
- Sanofi-aventis and Generics Leader Nichi-Iko to Establish New Joint Venture for Generics in Japan
- Novartis announces extension of US regulatory priority review period for FTY720
- Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology